Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SEP-4199
SEP-4199
Sunovion’s SEP-4199 fails to meet primary endpoint in SEP380-201 trial
Pharmaceutical Business Review
Tue, 07/7/20 - 10:45 am
Sunovion
clinical trials
SEP-4199
bipolar disorder